We performed a comprehensive quantification of 20 amino acids in RPMI 1640 medium-cultured human colorectal adenocarcinoma cells to evaluate the efficacy of 5-fluorouracil treatment under hypoxic and hypoglycemic conditions, which mimic the tumor microenvironment. In this study, we developed a simple and comprehensive analytical method by using LC-MS/MS connected to the Intrada amino acid column, which eluted amino acids within 9 min. The present method covered a linearity range of 3.6 -1818 μM, except for Gly (227 -1818 μM), Ala, Asp, His (7.1 -1818 μM each), and Trp (3.6 -909 μM). The limits of detection were in the range of 0.02 -38.0 pmol per injection in a standard solution. Amino acid concentration data were analyzed using principal-component analysis to represent samples on two-dimensional graphs. Linear discriminant analysis was used to classify samples on the score plots. Using this approach, the effect of 5-fluorouracil treatment could be successfully discriminated at high discrimination rates. Moreover, several amino acids were extracted from corresponding loading plots as candidate markers for distinguishing the effects of the 5-fluorouracil treatment or tumor microenvironmental conditions. These results suggest that our proposed method might be a useful tool for evaluating the efficacy of anticancer drugs in the tumor microenvironment.
Introduction
Metabolomics approaches are useful for simultaneously detecting changes in a wide variety of small molecules, and are typically used to monitor the response of cells or a complete organism to stimuli. [1] [2] [3] [4] Among the several available metabolomics approaches, amino acid metabolomics, which focuses on amino acids as key metabolites, including aminoindex 5, 6 and chiral amino acid metabolomics, [7] [8] [9] has been garnering intense research interest because of its potential utility and effectiveness in several fields, including for the diagnosis or monitoring of various pathological conditions.
In particular, in cancer metabolism, the uptake of amino acids into cancer cells is considered to be enhanced in comparison to that in normal cells. For instance, neutral amino acid transporters, such as ASCT2 and LAT1, are coordinately elevated in a wide spectrum of primary human cancers, suggesting that they are involved in the cancer metabolome. 10 Recently, we evaluated the effects of various anticancer drugs on cell growth using an amino acid metabolomics assessment of the cell culture medium. 11 The purpose of this previous study was to determine the therapeutic efficacy of anticancer drugs based on the changes in amino acid metabolism at the cellular level. Differences in the relative amino acid compositions of cells treated with three different anticancer drugs (5-fluorouracil , irinotecan hydrochloride, and cisplatin) were visualized through principal-component analysis (PCA) and partial leastsquares multivariate statistical analyses. Three amino acids (Ser, Asp, and Met) were elucidated from the loading plots as biomarkers to evaluate the effect of anticancer drugs.
In the present study, this same amino acid metabolomics strategy was successfully applied to evaluate the effects of hypoxia and hypoglycemia, which mimics the tumor microenvironment, on the sensitivity to an anticancer drug. Inner cells in cancer tissues tend to grow under hypoxic and hypoglycemic conditions because of aberrant neovascularization and poor blood flow; thus, the efficacy of anticancer drugs is greatly affected by the tumor microenvironment. Moreover, hypoxia, a common feature of malignancy particularly for solid tumors, is thought to promote tumor invasiveness and metastasis. 12, 13 The adoption of a metabolomics approach could also provide further understanding into the mechanisms of the drug resistance of cancer cells in the tumor microenvironment. For instance, by using CE-MS metabolomics, Esumi et al. 14 demonstrated that the metabolism of cancer cells differs under hypoxic and normoxic conditions, which ultimately affects the difference in the response to anticancer drugs. Furthermore, Onozuka et al. 15 revealed that PANC-1 cells cultured under a hypoglycemic/hypoxic condition, which mimics the tumor microenvironment, may reduce the efficacy of anticancer drugs. For comprehensive amino acids analysis, we established a novel intact LC-MS/MS method in place of our previously developed fluorescence derivatization-LC method using AccQTag.
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The previous method required a complicated derivatization procedure and a long time to complete the LC analysis. It also could not detect Trp. Therefore, a simple and rapid metabolomics method was needed to avoid a potential time-dependent alteration of the analytes. Amino acids were determined with an Intrada amino acid column, 16 which is a specialized column for intact amino acid analysis with LC-MS/ MS. This column could separate the structural isomers Leu and Ile successfully, and is applicable to β-and γ-amino acid isomers and dipeptides. Although this method requires an expensive LC-MS/MS apparatus, its analytical throughput is drastically improved compared to current methods, owing to the lack of requiring of a manual derivatization procedure. After method validation, we comprehensively quantified 20 amino acids in the RPMI 1640 culture medium for human colorectal adenocarcinoma cells (DLD-1 cells) that were treated with 5-FU, as a typical anticancer drug. To evaluate the efficacy of 5-FU in the tumor microenvironment, the DLD-1 cells were cultured under hypoglycemic/hypoxic conditions. Amino acid concentration data were analyzed by PCA multivariate statistical methods to represent samples on two-dimensional graphs, and hierarchical cluster analysis (CA) and linear discriminant analysis (DA) were, respectively, used to classify the samples and to distinguish the effects of the anticancer drug treatment on the PCA score plots. Moreover, the PCA loading plots were used to search for candidate amino acids that could serve as potential biomarkers to determine the response and effectiveness of 5-FU treatment.
Materials and Methods

Chemicals
The amino acid standard mixture solution, type H (mixture of 2.5 mM each of Asp, Ser, Glu, Gly, His, Arg, Thr, Ala, Pro, Tyr, Val, Met, Lys, Ile, Leu, Phe, and L-cystine [(Cys)2]), LC-grade acetonitrile, and dimethyl sulfoxide (DMSO) were purchased from Wako Pure Chemical Industries (Osaka, Japan). Distilled water, LC-grade tetrahydrofuran (THF), formic acid, and nonessential amino acids solution were obtained from Nacalai Tesque (Kyoto, Japan). Asn monohydrate, Gln, and Trp were purchased from Tokyo Chemical Industry (Tokyo, Japan). Ammonium formate was purchased from Kanto Chemical (Tokyo, Japan). RPMI 1640 containing glucose, glucose-free RPMI 1640, fetal bovine serum (FBS), and kanamycin sulfate were purchased from Gibco (Auckland, New Zealand). 5-FU and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) were obtained from Sigma Aldrich (St. Louis, MO) and Dojindo Laboratories (Kumamoto, Japan), respectively. Stable isotope-labeled amino acids, including L-glutamic-2,3,3,4,4-d5 acid (Glu-d5), L-histidine-d3 (α-d1; imidazole-2,5-d2) hydrochloride monohydrate (His-d3), L-lysine-3,3,4,4,5,5,6,6,-d8 monohydrochloride (Lys-d8), L-phenyl-d5-alanine (Phe-d5), and L-valine-2,3,4,4,4,4′,4′,4′-d8 (Val-d8), were purchased from CDN Isotopes Inc. (Quebec, Canada).
LC-MS/MS conditions
LC-MS/MS analysis was performed using a Prominence ultrafast liquid chromatography system (Shimadzu, Kyoto, Japan) coupled with an API 4000 Qtrap tandem mass spectrometer (AB Sciex, Concord, Ontario, Canada) with an ESI interface. Data acquisition was controlled using the Analyst software Ver. 1.4.2 (AB Sciex). The analytical column used was an Intrada amino acid column (100 × 3 mm i.d., 3 μm; Imtakt, Kyoto, Japan) maintained at 40 C. The mobile phases consisted of solvent A (acetonitrile-THF-25 mM ammonium formate-formic acid = 9:75:16:0.3, v/v/v/v) and solvent B (acetonitrile-100 mM ammonium formate = 1:4, v/v). The optimized gradient profile involved an isocratic elution as follows: 0% solvent B at 0 min, 0% solvent B at 2 min, 17% solvent B at 3.9 min, 100% solvent B at 4 min, 100% solvent B at 8 min, and 0% solvent B at 8.01 min with a flow rate of 0.7 mL min -1 . The total run time was 11 min. The injection volume was 1 μL and the effluent from the LC column was directly introduced into the ion source of the mass spectrometer without splitting.
The mass spectrometer was operated in the multiple reaction monitoring (MRM) mode using positive ESI. The parameters for the MRM analysis were as follows: capillary voltage of 5500 V, source temperature at 500 C, curtain gas of 10 (arbitrary units), ion source gas 1 pressure setting of 80 (arbitrary units) and ion source gas 2 setting of 60 (arbitrary units), declustering potential of 40 V, and entrance potential of 10 V. MRM transition of the precursor to product ions used for quantification, collision energy, collision cell exit potential, and ISs of the analytes are summarized in Table 1 .
Standard stock solutions
Each solution of Asn (250 mM), Gln (250 mM), and Trp (100 mM) was prepared in 0.1 M hydrochloric acid. A standard stock solution containing a mixture of 20 amino acids (2.27 mM) was prepared by mixing a solution containing 17 standards, and the prepared solutions of Asn, Gln, and Trp, respectively. A solution of 5-FU was prepared in DMSO and further diluted to the required concentrations with culture medium just before use. The solutions (100 mM each) of Glu-d5, His-d3, Lys-d8, Phe-d5, and Val-d8 were prepared in 0.1 M hydrochloric acid, and were mixed and diluted to 1 mM with methanol as an internal standard (IS) solution containing 5 stable isotopelabeled amino acids. These stock solutions were stored at 4 C.
Cell culture sample preparation
The human colorectal adenocarcinoma DLD-1 cells were obtained from DS Pharma Biomedical (Osaka, Japan). The DLD-1 cells were cultured in RPMI 1640 medium with 10% FBS, 1% kanamycin sulfate, and 1% nonessential amino acids solution at 37 C under 5% CO2. The cells were sub-cultured when they were observed to be 80% confluent in the flask. Measurements of the cell viability by the MTT assay were used to calculate the half-maximal inhibitory concentration (IC50) value. Briefly, cells (7.5 × 10 4 cells mL -1 ) were incubated in 100 μL of culture medium containing 5-FU (from 0.1 to 50 μg mL -1 ) for 72 h. The cells were incubated with 10 μL of a MTT reagent solution for the last 2 h. After removal of the medium, 100 μL DMSO was added to each well for the dissolution of MTT-formazan, and the absorbance was measured at 570 nm using a Sunrise Rainbow RC-R microplate reader (TECAN, Männedorf, Switzerland). Each assay was performed in triplicate. A glucose-free medium was used for evaluations under a nutrient starvation condition. The hypoxic condition was generated by incubating the cells with O2-absorbing agents (anaerobic culture set FX-4, Cosmo Bio, Tokyo, Japan) in a sealed bag until a 5% O2 concentration was achieved. The culture media were bubbled with nitrogen gas just before use so as to remove dissolved oxygen. Cells cultured with RPMI 1640 containing glucose under normoxic conditions were used as culture controls. The viable cell count was determined by trypan blue staining.
For the amino acid metabolomics analysis, cells (7.5 × 10 4 cells mL -1 ) were seeded in 100 μL of a culture medium containing 5-FU for 72 h with O2-absorbing agents in a sealed bag. At 0, 12, 24, 36, 48, 60, and 72 h from the beginning of the incubation, 30-μL samples of the medium were collected into 1.5-mL centrifuge tubes. After the addition of 105 μL of ice-cold methanol and 15 μL of a 1 mM internal standard mixture solution, the mixture was vortexed and centrifuged at 16000g for 5 min at 4 C; the resulting supernatant was stored at -80 C until analysis. The supernatants were diluted with the mobile phase A, and then injected into the LC system.
Method validation
Calibration solutions were prepared from the stock solutions at concentrations ranging from 3.6 to 1818 μM. Calibration curves were constructed by plotting the nominal concentration versus the peak-area ratio, and were fitted using a least-squares regression. The LOD was determined from a signal-to-noise ratio of 3. Intra-and inter-day precisions were estimated using the standard solution (227 μM) and a spiked standard solution in the medium; measurements were taken three times on the same day or for three days, respectively. The precision value was obtained as the coefficient of variation (relative standard deviation of peak-area, %). The accuracy was determined using the spiked standard solution into medium (455 μM), and measurements were taken three times on the same day and calculated according to the following formula: [(concentration in spiked medium -concentration in non-spiked medium)/added concentration]× 100. The acceptable precision level was defined to be less than 20%.
Extraction recovery
The extraction recovery was determined by comparing the response of the standard solutions spiked at the same levels into the medium before and after extraction. One set of samples was prepared by adding standard solutions (455 μM) into the medium, followed by extraction. Another set was prepared by combining the same levels of standard solutions with the previously extracted medium. The extraction recovery was calculated to be 100 ×[(response in spiked medium -response in non-spiked medium)/response in medium that was spiked after extraction].
Statistical analysis
A statistical analysis of amino acid concentrations in each medium sample was performed according to the same procedure as previously reported. 11 These concentrations are presented as the average of three repeated measurements. During this process, Smirnov-Grubbs' rejection test 17, 18 was performed using Eq. (1) to identify outliers:
where x* is the outlier value, μ is the sample average, and σ is the standard deviation of measured values. If the normalized variate was higher than 1.153, which is a critical value (n = 3, p value = 0.05), the value was rejected. Since the concentrations of the 20 amino acids in the culture medium were very different in the individual analyses, the concentration data were normalized using Eq. (2):
where x is the measured concentration, μ is the average of concentrations measured from 0 to 72 h, and σ is the standard deviation of the concentrations measured from 0 to 72 h. The calculated normalized values were exported to SIMCA-P+ software 12.0 (Umetrics, Umeå, Sweden) for multivariate statistical analyses, and three principal components were calculated (PC1, PC2, and PC3). The contribution ratios represented the contribution of a component to the total variance in the data. The DA and the CA were sequentially carried out using Ward's minimum variance method with SPSS Statistics 22 Ver. 3 software (IBM Japan, Tokyo, Japan). According to the dendrogram (tree diagram) obtained from the CA, each sample was classified into several groups, which were compared to the PCA score plots. The discrimination rate was calculated using Eq. (3):
Discrimination rate (%) = (Ndet/Ntotal)× 100,
where Ndet is the number of correctly determined samples, and Ntotal is the total number of samples.
Results and Discussion
LC-MS/MS
For this amino acid metabolomics study, rapid and simple pretreatment of samples and the complete separation of amino acid isomers, especially between Leu and Ile, were required. Thus, we selected the Intrada amino acid column that is specifically designed for the LC-MS analysis of intact amino acids, and modified the flow rate and gradient profile so as to shorten the analysis time, while keeping the complete separation of Leu and Ile. The optimized precursor ion (Q1) and product ion (Q3) for each amino acid are summarized in Table 1 . The Intrada amino acid column eluted amino acids within 9 min with gradient elution using a mixture of aqueous ammonium formate, THF, acetonitrile, and formic acid as the mobile phases. Figure 1 shows a typical MRM chromatogram of the standard 20 amino acids and 5 stable isotope-labeled amino acids (Glu-d5, His-d3, Lys-d8, Phe-d5, and Val-d8).
Although detailed information of the separation mode of the Intrada amino acid column has not been released by the supplier, it is known that the separation mode of the column is a combination of hydrophilic interaction and cation-exchange modes. Therefore, hydrophobic amino acids were readily eluted from the column; in particular, the Trp peak was observed, which could not be determined by our previous method. 11 The peaks of Ile and Leu, which have similar lipophilicity and the same MRM transitions, could be successfully separated with a resolution (Rs) of 1.67. Overlapping peaks from LC could be separated in the m/z dimension. Compared to our previous method, the sample preparation procedure and the total LC analysis time, including the column washing and equilibration steps, were simplified and shortened from 60 to 11 min.
Method validation
The results of the analytical method validation are summarized in Table 2 . The quantification of amino acids was performed by calculating the peak-area ratios of the analytes and their corresponding IS compounds, listed in Table 1 . The present method covered a linearity range of 3.6 -1818 μM with triplicates, except for Gly (227 -1818 μM), Ala, Asp, His (7.1 -1818 μM each), and Trp (3.6 -909 μM). The calibration curves for all amino acids showed a strong correlation (r 2 > 0.9953) between the peak-area ratios toward IS compounds and the analyte concentration. The LODs were in the range of 0.02 -38.0 pmol per injection, which corresponds to 0.1 -190.1 μM in the standard solution. The intra-day and inter-day precision of all amino acids of the standard solution were in the range of 0.8 -3.6 and 2.4 -17.1%, respectively, and those of the spiked standard solution were in the range of 1.3 -9.6 and 4.8 -21.7%, respectively. The accuracy values for all amino acids were in the range of 89.8 -117.6%. Therefore, the precision and accuracy data were within acceptable ranges, indicating the feasibility of the method.
We selected methanol deproteinization as the optimal pretreatment for the medium samples. Recovery studies for the method were performed by spiking 455 μM amino acids into RPMI 1640 medium samples. The recoveries were calculated by comparing the response of the spiked medium samples before and after extraction (n = 3 each). The mean recoveries of all amino acids were in the range of 87.7 -133.1%. Fig. 1 Typical MRM chromatograms of 20 standard amino acids and 5 stable isotope-labeled amino acids (Glu-d5, His-d3, Lys-d8, Phe-d5, and Val-d8). The precursor ion (Q1) and product ion (Q3) for each amino acid were set as described in Table 1 . The numbers next to the amino acid labels indicate the expansion of the peak intensity.
Cancer cell growth under normoglycemic/normoxic and hypoglycemic/hypoxic conditions
We applied the validated method to a metabolomics analysis. DLD-1 cells were cultured in the RPMI 1640 medium treated with the IC50 concentration (20 μg mL glucose)/normoxic (21% O2) or hypoglycemic (0 g L -1 glucose)/hypoxic (5% O2) conditions for 72 h. The IC50 value of 5-FU was estimated from the results of the MTT assay. Figure 2 shows the relative survival rates of the DLD-1 cells treated with 5-FU under the normoglycemic/ normoxic (Fig. 2a) and hypoglycemic/hypoxic (Fig. 2b) conditions. Under the normoglycemic/normoxic condition, the cell viability decreased to about 45% compared to that of the control. In contrast, 95% of the 5-FU-treated cells survived under hypoglycemic/hypoxic conditions. To confirm this drug resistance, the viable cell count was determined by trypan blue staining. Under normoglycemic/normoxic conditions, viable counts of DLD-1 cells increased from 7.5 × 10 4 cells mL -1
(initial state) to 23 × 10 4 cells mL -1 (48 h). By contrast, the viable cell counts were almost the same (8.0 × 10 4 cells mL -1 ) after 48 h under hypoglycemic/hypoxic conditions. Moreover, there were barely any dead cells identified. Thus, cell growth would be intensely suppressed under hypoglycemic/hypoxic conditions. 5-FU exhibits strong effects, especially to cells with rapid metabolic rates. The mechanism of cytotoxicity of 5-FU has been ascribed to the misincorporation of fluoronucleotides into RNA and DNA, and to the inhibition of the nucleotide synthetic enzyme thymidylate synthase. 19 Thus, cell growth can be intensely suppressed by a change in the microenvironment, which generates the development of drug resistance. According to these results, we attempted to link these differences to the observed change of the amino acid levels.
Resistance of cancer cells toward 5-FU in a simulated tumor microenvironment
The amino acid concentrations in the RPMI 1640 medium of cultured DLD-1 cells were analyzed by PCA to represent the samples on two-dimensional graphs. Hierarchical CA and linear DA were then used to classify the samples on the score plots. Figure 3 depicts the PCA score plots of data obtained from the analysis of the DLD-1 cell culture medium treated with and without 5-FU under either normoglycemic/normoxic or hypoglycemic/hypoxic conditions. Each plot was classified using the CA and the DA approach. Using the PCA score plot, any differences in the amino acids composition of each sample could be visually represented in the coordinates on the twodimensional graphs.
Under normoglycemic/normoxic conditions, the sum of the contribution ratios of PC1 and PC2 from the PCA score plot showed that these two coordinates a. Correlation coefficient of the amino acid calibration curve in each range. b. Defined as a signal-to-noise ratio of 3. c. Percent ratio of peak-area for 455 μM amino acid spiked into the medium before and after deproteinization. d. Relative standard derivation of the peak-area of 227 μM amino acid in standard solution and spiked standard solution into the medium. e. Percent ratio of peak-area for 455 μM amino acid spiked into the medium and the standard solution. accounted for 82.7% of the variance in the data. Although this value could explain the overall trend of the 5-FU effect, the variability could not be discriminated using either the CA or the DA approach (data not shown). The plot of PC1 and PC3 showed that these two coordinates accounted for 80.2% of the variance, and the DA approach could successfully discriminate the differences of the effect of 5-FU (Fig. 3a) . Under hypoxic and hypoglycemic conditions, the sum of the contribution of PC1 and PC2 to the total variation was 73.6%. This value could fully explain the overall detected trend; however, differences of the treatment with and without 5-FU were not clustered by CA and could not be distinguished by DA, showing a low discrimination rate (64.3%). In the cell viability experiment (Fig. 2b) , no dramatic decrease of cell viability by 5-FU treatment was observed under hypoglycemic/hypoxic conditions, which agreed well with results of the PCA-DA analysis. These results suggested that the effectiveness of 5-FU could be assessed by discriminating between the 5-FU-treated groups and untreated groups on the score plot. Namely, our proposed method might be a useful tool for evaluating of the efficacy of anticancer drugs in the tumor microenvironment.
We next compared the two groups, i.e., those cultured under normoglycemic/normoxic and hypoglycemic/hypoxic conditions without 5-FU treatment, using PCA-CA and PCA-DA (Fig. 3c) . The sum of the contributions of PC1 and PC2 was 83.5%, which could successfully discriminate between cells grown under the different culture conditions at a high discrimination rate (92.9%) using the DA approach.
The PCA loading plots from each of the analyses depicted in Fig. 3 are presented in Fig. 4 . Under the normoglycemic/ normoxic condition, all amino acids contributed to distinguishing between groups in all directions of the PCA-DA plot (Fig. 4a) . However, Ala, Glu, and Gly were apart from the rest of the amino acids, and stood on a diagonal coordinate to the others in the plot. This result suggested that these three amino acids have a major contribution to the differences observed between the 5-FU-treated group and the control samples. Interestingly, similar results were obtained when only the 5-FU-untreated groups were compared, and same three amino acids also contributed significantly to the differences observed between the groups cultured under normoglycemic/normoxic and hypoglycemic/hypoxic conditions (Fig. 4c) . In contrast, the remarkable amino acids were not identified under the hypoglycemic/hypoxic conditions, since almost all of the amino acids contributed uniformly in all directions in the PCA-DA (Fig. 4b) . Ala, Glu, and Gly are involved in glycolysis and the tricarboxylic acid (TCA) cycle. Therefore, the concentration profiles of these and other amino acids related to these cycles (Asn, Asp, and Gln) are shown on a metabolic pathway map in Fig. 5 . The Ala concentrations measured under the hypoglycemic/ hypoxic conditions were lower than those measured under the normoglycemic/normoxic conditions, which was due to the suppression of glycolysis. However, under the hypoglycemic/ hypoxic conditions, the transformation of Gln and the accumulation of Glu would cause an increase in the Glu level because of suppression of the TCA cycle.
In Figs. 4a and 4c , the same three amino acids (Ala, Glu, and Gly) were extracted as candidate biomarkers, indicating a role in the cell growth inhibition. Although Gly was also extracted as a marker candidate, no significant difference was found because of its high LOD. These results suggest that Ala and Glu are both marker candidates for evaluating the effect of 5-FU and for discriminating hypoglycemic/hypoxic (i.e., tumor microenvironment) conditions. These findings agreed well with those of previous studies regarding the effects of hypoxia and hypoglycemia.
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Conclusions
We established a new, simple, and comprehensive analytical method for the quantification of amino acids in a cell culture medium using LC-MS/MS. All of the amino acids examined could be determined within 9 min using an Intrada amino acid column without a complicated derivatization procedure. After a method validation, we comprehensively quantified 20 amino acids in the RPMI 1640 medium of cultured DLD-1 cells to evaluate the efficacy of 5-FU in the tumor microenvironment. Using the PCA-DA statistical approach, the effect of 5-FU treatment could be successfully distinguished at high discrimination rates. Moreover, three amino acids (Ala, Glu, and Gly) were extracted from the loading plots as candidate biomarkers, which could discriminate between tumor and nontumor microenvironmental conditions. These results indicate the feasibility of our proposed method for assessing the effectiveness of several anticancer drugs in the tumor microenvironment. 
